1. Home
  2. MTH vs MDGL Comparison

MTH vs MDGL Comparison

Compare MTH & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTH
  • MDGL
  • Stock Information
  • Founded
  • MTH 1985
  • MDGL 2011
  • Country
  • MTH United States
  • MDGL United States
  • Employees
  • MTH N/A
  • MDGL N/A
  • Industry
  • MTH Homebuilding
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTH Consumer Discretionary
  • MDGL Health Care
  • Exchange
  • MTH Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • MTH 4.9B
  • MDGL 6.1B
  • IPO Year
  • MTH 1988
  • MDGL N/A
  • Fundamental
  • Price
  • MTH $73.99
  • MDGL $314.31
  • Analyst Decision
  • MTH Buy
  • MDGL Strong Buy
  • Analyst Count
  • MTH 10
  • MDGL 9
  • Target Price
  • MTH $74.42
  • MDGL $420.63
  • AVG Volume (30 Days)
  • MTH 1.0M
  • MDGL 286.7K
  • Earning Date
  • MTH 07-23-2025
  • MDGL 08-06-2025
  • Dividend Yield
  • MTH 2.28%
  • MDGL N/A
  • EPS Growth
  • MTH N/A
  • MDGL N/A
  • EPS
  • MTH 9.89
  • MDGL N/A
  • Revenue
  • MTH $6,284,888,000.00
  • MDGL $317,383,000.00
  • Revenue This Year
  • MTH $3.99
  • MDGL $286.17
  • Revenue Next Year
  • MTH $7.59
  • MDGL $64.17
  • P/E Ratio
  • MTH $7.46
  • MDGL N/A
  • Revenue Growth
  • MTH N/A
  • MDGL N/A
  • 52 Week Low
  • MTH $59.27
  • MDGL $200.63
  • 52 Week High
  • MTH $106.99
  • MDGL $377.46
  • Technical
  • Relative Strength Index (RSI)
  • MTH 64.26
  • MDGL 64.53
  • Support Level
  • MTH $67.88
  • MDGL $284.02
  • Resistance Level
  • MTH $76.59
  • MDGL $311.21
  • Average True Range (ATR)
  • MTH 2.64
  • MDGL 11.94
  • MACD
  • MTH 0.86
  • MDGL 2.74
  • Stochastic Oscillator
  • MTH 83.45
  • MDGL 100.00

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: